BioThrax (Emergent BioDefense Operations Lansing, LLC)


Welcome to the PulseAid listing for the BioThrax drug offered from Emergent BioDefense Operations Lansing, LLC. This Live Attenuated Bacillus Anthracis Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Attenuated [Chemical/Ingredient],Anthrax Vaccines [Chemical/Ingredient] pharmaceutical is classified as a VACCINE. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same VACCINE drug type category.

LABELER NAME / MANUFACTURER: Emergent BioDefense Operations Lansing, LLC
NON-PROPRIETARY NAME: BACILLUS ANTHRACIS
SUBSTANCE NAME: BACILLUS ANTHRACIS STRAIN V770-NP1-R ANTIGENS
TYPE: VACCINE
PHARMA CLASS: Live Attenuated Bacillus Anthracis Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Attenuated [Chemical/Ingredient],Anthrax Vaccines [Chemical/Ingredient]
ROUTE: INTRAMUSCULAR; SUBCUTANEOUS
DOSAGE FORM: INJECTION, SUSPENSION
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 1970-11-04
END MARKETING DATE: 0000-00-00


BioThrax VACCINE Details:

Item DescriptionBioThrax from Emergent BioDefense Operations Lansing, LLC
LABELER NAME: Emergent BioDefense Operations Lansing, LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 100(ug/mL)
START MARKETING DATE: 1970-11-04
END MARKETING DATE: 0000-00-00
PRODUCT ID: 64678-211_f5796150-9f9e-11e5-a837-0800200c9a66
PRODUCT NDC: 64678-211
APPLICATION NUMBER: BLA103821

Other BACILLUS ANTHRACIS STRAIN V770-NP1-R ANTIGENS Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Emergent BioDefense Operations Lansing, LLCBioThrax